ARG2 and COVID-19: In addition, studies have characterized the cumulative expression of ARG2 in lung myeloid cells in the severe COVID-19, thermal injury, and lung metastasis model of breast cancer to induce diminished immune surveillance 57-59, suggesting that the alveolar space could provide a permissive environment for ARG2-mediated immunosuppression.